Maackiain (1) was transformed by Beauveria bassiana and Cunninghamella echinulata var. elegans to yield a new methylglycosylation product, (-)-maackiain-3-O-(4 -O-methyl--D-glucopyranoside) (2, 90%) and known trifolirhizin (3, 16%). The kinetics of the two glycosylation reactions was investigated. Additionally, 3 was converted to 2 via 4 -methylation by B. bassiana, which implied that the 4 -methylglycosylation mechanism of (-)-maackiain by B. bassiana is glycosylation followed by methylation. The antioxidant, antifungal, cytotoxic and DNA topoisomerase I inhibition bioactivities of 1, 2 and 3 were tested. Compounds 2 and 3 showed in vitro cytotoxicity against a leukemia cell line (HL-60) with GI 50 at 56.3 9.5 and 46.5 5.2 μM, respectively. However, the cytoxicity of 1 was measured as GI 50 100 μM.